MedPath

A comparison study of leukotriene receptor antagonist plus topical nasal steroid versus oral antihistamine + topical nasal steroid versus leukotriene receptor antagonist + oral antihistamine + topical nasal in the treatment of perennial allergic rhinitis

Completed
Conditions
Respiratory: Allergic rhinitis
Respiratory
Perennial allergic rhinitis
Registration Number
ISRCTN02329306
Lead Sponsor
Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
60
Inclusion Criteria

60 patients (20 in each group), patients seen in out-patients with symptoms, signs and test results consistent with perennial allergic rhinitis will be placed on a six-week course of topical nasal steroid spray.

Exclusion Criteria

Not provided at time of registration

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Symptom scores at 12 week assessment
Secondary Outcome Measures
NameTimeMethod
ot provided at time of registration<br>
© Copyright 2025. All Rights Reserved by MedPath